Veradigm Inc (MDRX) Stock Price, Trades & News

Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.

Financial Strength

3/10

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	34.83
	9-Day RSI	41
	14-Day RSI	44.8
	3-1 Month Momentum %	2.04
	6-1 Month Momentum %	2.04
	12-1 Month Momentum %	1.21

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	14.01
	OCF Margin %	19.44

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	15.83
	PE Ratio without NRI	11.88
	EV-to-EBIT	-5.21
	EV-to-Forward-EBIT	14.08
	EV-to-EBITDA	-5.96
	EV-to-Forward-EBITDA	5.53
	EV-to-Revenue	0.76
	EV-to-Forward-Revenue	1.3
	EV-to-FCF	5.41
	Earnings Yield (Greenblatt) %	-19.19
	FCF Yield %	16.09

GF Value™

MDRX

Warning Signs

Warning! GuruFocus detected issues with MDRX. Try a 7-Day Free Trial to check it out.

Veradigm Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Veradigm Inc Stock Events

Financials Calendars

Event	Date	Price ($)
Fourth quarter earnings conference call for 2026	2027-02-15 08:00	In 172 days
Fourth quarter earnings results for 2026	2027-02-15	In 171 days
Third quarter earnings conference call for 2026	2026-11-13	In 77 days
Third quarter earnings results for 2026	2026-11-13	In 77 days
Second quarter earnings conference call for 2026	2026-10-01 08:00	In 35 days
Second quarter earnings results for 2026	2026-09-30	In 33 days
Guidance call for 2026	2026-09-16	In 19 days
Guidance call for 2026	2026-09-15 16:10	In 19 days
First quarter earnings conference call for 2026	2026-09-01	In 4 days
First quarter earnings results for 2026	2026-09-01	In 4 days

Show

Entries

Guru Commentaries on OTCPK:MDRX

No fund manager commentary yet.

Browse all fund letters →

Press Release

	Subject	Date
	Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation	2024-03-26
	Sprinklr Set to Join S&P SmallCap 600	2024-02-28
	Veradigm Receives Expected Delisting Notice from Nasdaq	2024-02-28
	Veradigm to Participate in TD Cowen Annual Health Care Conference	2024-02-28
	Veradigm Provides Update on its Financial Restatement Process	2024-02-27
	Veradigm to Acquire ScienceIO	2024-02-27
	Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference	2024-02-22
	Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.	2024-02-20
	Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health	2024-02-13
	Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation	2024-02-12

10/Page

Articles on Veradigm Inc

MDRX

8-K - Veradigm Inc. (0001124804)

Aug 17, 2026

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.